IKT Archived Articles
Inhibikase Therapeutics (NASDAQ:IKT) Pioneering New Treatments for Debilitating Diseases
Published on March 11, 2025
Inhibikase Therapeutics (IKT): Navigating the Frontier of Neurodegenerative and Cardiopulmonary Therapies
Published on November 26, 2024
Inhibikase Therapeutics, Inc. (NASDAQ:IKT): Advancing Innovative Therapies for Parkinson's and Beyond
Published on September 24, 2024